Keyphrases
Non-Hodgkin Lymphoma
100%
Autologous Transplantation
100%
Large Cell
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
80%
High-dose Chemotherapy
80%
Good Prognosis
60%
Histology
40%
Chemotherapy Regimen
40%
5-year Survival
40%
Prior Chemotherapy
40%
Diffuse Large Cell
40%
Lactic Dehydrogenase
40%
Diffuse Histology
40%
Multivariate Analysis
20%
Failure-free Survival
20%
Prognostic Factors
20%
Follow-up Interval
20%
Improved Survival
20%
Chemotherapy Resistance
20%
Good Prognosis Group
20%
Large B-cell Lymphoma
20%
Large Mass
20%
Failure-free
20%
Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Large Cell
100%
Autotransplantation
100%
High Dose Chemotherapy
57%
Autologous Hematopoietic Stem Cell Transplantation
57%
Transplantation
28%
Survival Rate
28%
Lactate Dehydrogenase
28%
Patient History of Chemotherapy
28%
Chemotherapy Regimens
28%
Multivariate Analysis
14%
Failure Free Survival
14%
Prognostic Factor
14%
Large-Cell Lymphoma
14%
Immunology and Microbiology
Drug Megadose
100%
Autologous Hematopoietic Stem Cell Transplantation
100%
Autotransplantation
100%
Transplant Procedure
50%
Survival Rate
50%
Lymphoma Cell
25%
Failure Free Survival
25%